Predicting the 1p/19q co-deletion status of presumed low grade glioma with an externally validated machine learning algorithm.
Clicks: 350
ID: 52535
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
68.0
/100
350 views
237 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #8 of 11 articles by views in clinical cancer research : an official journal of the american association for cancer research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Patients with 1p/19q co-deleted low grade glioma (LGG) have longer overall survival and better treatment response than patients with 1p/19q intact tumors. Therefore, it is relevant to know the 1p/19q status. To investigate whether the 1p/19q status can be assessed prior to tumor resection, we developed a machine learning algorithm to predict the 1p/19q status of presumed LGG based on preoperative magnetic resonance imaging (MRI).Preoperative brain MRI scans from 284 patients who had undergone biopsy or resection of presumed LGG were used to train a support vector machine algorithm. The algorithm was trained based on features extracted from T1-weighted and T2-weighted MRI scans, and on patient age and sex. The performance of the algorithm compared to tissue diagnosis was assessed on an external validation dataset of MRI scans from 129 LGG patients from The Cancer Imaging Archive (TCIA). Four clinical experts also predicted the 1p/19q status of the TCIA MRI scans.The algorithm achieved an area under the curve (AUC) of 0.72 in the external validation dataset. The algorithm had a higher predictive performance than the average of the neurosurgeons (AUC 0.52), but lower than that of the neuroradiologists (AUC 0.81). There was a wide variability between clinical experts (AUC 0.45-0.83).Our results suggest that our algorithm can non-invasively predict the 1p/19q status of presumed LGG with a performance that on average outperformed the oncological neurosurgeons . Evaluation on an independent dataset indicates that our algorithm is robust and generalizable.
| Reference Key |
van-der-voort2019predictingclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | van der Voort, Sebastian R;Incekara, Fatih;Wijnenga, Maarten Mj;Kapsas, Georgios;Gardeniers, Mayke;Schouten, Joost W;Starmans, Martijn Pa;Nandoe Tewarie, Rishie;Lycklama, Geert J;French, Pim J;Dubbink, Hendrikus J;van den Bent, Martin J;Vincent, Arnaud Jpe;Niessen, Wiro J;Klein, Stefan;Smits, Marion; |
| Journal | clinical cancer research : an official journal of the american association for cancer research |
| Year | 2019 |
| DOI |
clincanres.1127.2019
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.